Chronic Lymphocytic Leukemia (CLL) Cells Genetically Modified to Express B7-1, ICAM-1, and LFA-3 Confer APC Capacity to T Cells From CLL Patients
Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-008-0611-5
Full Text
Open PDFAbstract
Available in full text
Date
November 14, 2008
Authors
Publisher
Springer Science and Business Media LLC